4569 On Other Exchanges
4569 is not on other exchanges.

Executive Profile*

John W. Kozarich Ph.D.

AgeTotal Calculated CompensationThis person is connected to 63 board members in 8 different organizations across 11 different industries.

See Board Relationships


Dr. John W. Kozarich, Ph.D., has been an Advisor of Corium International, Inc. since April 1, 2015. Dr. Kozarich served as the Chief Scientific Advisor of KYORIN Holdings, Inc. since February 2005. He served as the Chairman and President at ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Holdings and KYORIN Pharmaceutical Co., Ltd. since February 2005. He also served as Scientific Advisor at Ligand Pharmaceuticals Incorporated. He joined ActivX Biosciences ...

Read Full Background

Corporate Headquarters*

6, Kanda Surugadai 4-chome
Tokyo, -- 101-8311


Phone: 81 3 3525 4700
Fax: --

Board Members Memberships*

Chairman and President
Chairman and Member of Nominating & Corporate Governance Committee
Independent Director and Chairman of Scientific Review Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Chairman of the Board


Post-Doctoral Training
Harvard University
Massachusetts Institute of Technology
Boston College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$15,500
Total Calculated Compensation$44,706
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
Hirotaka Nakatomi Chairman, Chief Executive Officer and Chairman of Crisis Management Committee
Hisamitsu Pharmaceutical Co., Inc.
Stephen J. Farr Ph.D.Co-Founder, Chief Executive Officer, President and Director
Zogenix, Inc.
Konstantinos Alataris Ph.D.Chief Executive Officer, President and Director
Zosano Pharma Corporation
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KYORIN HOLDINGS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.